Suppr超能文献

山羊中使用心房特异性和非特异性III类药物联合进行持续性心房颤动复律

Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat.

作者信息

Blaauw Y, Schotten U, van Hunnik A, Neuberger H R, Allessie M A

机构信息

Department of Physiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, The Netherlands.

出版信息

Cardiovasc Res. 2007 Jul 1;75(1):89-98. doi: 10.1016/j.cardiores.2007.03.021. Epub 2007 Mar 30.

Abstract

OBJECTIVE

In electrically remodeled atria the effect of blockers of the delayed rectifier K+ current I(Kr) on repolarization is reduced, whereas the efficacy of 'early' class III drugs (I(Kur)/I(to)/I(Kach) blockers) is enhanced. We evaluated the electrophysiological and antifibrillatory effects of AVE0118, dofetilide, and ibutilide (alone and in combination) on persistent atrial fibrillation (AF) in the goat.

METHODS AND RESULTS

The effects of separate and combined administration of AVE0118, dofetilide, and ibutilide were determined before and after 48 h of AF. AVE0118 alone markedly prolonged the atrial refractory period (400 ms cycle length) (AERP400) before and after 48 h of AF. The prolongation of AERP(400) by dofetilide and ibutilide, respectively, was reduced by AF from 22+/-2 to 7+/-2 ms (p<0.01) and 25+/-5 to 5+/-2 ms (p=0.01). Pre-treatment with AVE0118 restored the prolongation of AERP400 by dofetilide or ibutilide (to 20+/-3 and 30+/-6 ms; p<0.01). This effect was atrial specific since the QT-interval was not changed. The antifibrillatory action was evaluated in 10 goats that were in persistent AF for 57+/-7 days. Dofetilide (20 microg/kg/h) or ibutilide (4 mg/h) alone restored sinus rhythm in only 20% of the animals. AVE0118 (1, 3 and 10 mg/kg/h) [DOSAGE ERROR CORRECTED] terminated AF in 11, 30, and 60%, respectively. Additional infusion of I(Kr) blockers caused an additional number of cardioversions, resulting in a final cardioversion rate of 56, 80, and 100%, respectively. AVE0118 alone prolonged the AF cycle length (AFCL) while the conduction velocity during AF (CV(AF)) remained unchanged (70+/-1 vs. 68+/-2 cm/s; p=0.3). Addition of dofetilide or ibutilide caused a synergistic increase in AFCL and a slight increase in CV(AF) to 74+/-1 cm/s (p<0.001). The length of the reentrant trajectories increased from 7.6+/-0.3 (control) to 11.6+/-0.5 cm after AVE0118 alone (p<0.001) and 14.8+/-0.8 cm after addition of dofetilide or ibutilide (p<0.001).

CONCLUSIONS

In electrically remodeled atria, blockade of I(Kur)/I(to)/I(KAch) restored the class III action of I(Kr) blockers. Persistent AF could be effectively cardioverted by infusion of a combination of AVE0118 and dofetilide or ibutilide. This antifibrillatory action was associated with an almost twofold lengthening of the intra-atrial pathways for reentry.

摘要

目的

在电重构心房中,延迟整流钾电流I(Kr)阻滞剂对复极化的作用减弱,而“早期”Ⅲ类药物(I(Kur)/I(to)/I(Kach)阻滞剂)的疗效增强。我们评估了AVE0118、多非利特和伊布利特(单独及联合使用)对山羊持续性心房颤动(AF)的电生理和抗纤颤作用。

方法与结果

在AF持续48小时前后,分别测定了AVE0118、多非利特和伊布利特单独及联合给药的效果。单独使用AVE0118在AF持续48小时前后均显著延长心房不应期(周长400 ms)(AERP400)。AF使多非利特和伊布利特分别引起的AERP(400)延长从22±2 ms降至7±2 ms(p<0.01)以及从25±5 ms降至5±2 ms(p=0.01)。用AVE0118预处理可使多非利特或伊布利特引起的AERP400延长恢复(分别至20±3 ms和30±6 ms;p<0.01)。由于QT间期未改变,此作用具有心房特异性。在10只持续性AF达57±7天的山羊中评估了抗纤颤作用。单独使用多非利特(20 μg/kg/h)或伊布利特(4 mg/h)仅使20%的动物恢复窦性心律。AVE0118(1、3和10 mg/kg/h)[剂量错误已纠正]分别使11%、30%和60%的AF终止。额外输注I(Kr)阻滞剂导致更多的复律,最终复律率分别为56%、80%和100%。单独使用AVE0118可延长AF周长(AFCL),而AF期间的传导速度(CV(AF))保持不变(70±1 cm/s对68±2 cm/s;p=0.3)。加入多非利特或伊布利特可协同增加AFCL,并使CV(AF)轻微增加至74±1 cm/s(p<0.001)。单独使用AVE0118后折返径路长度从7.6±0.3 cm(对照)增加至11.6±0.5 cm(p<0.001),加入多非利特或伊布利特后增加至14.8±0.8 cm(p<0.001)。

结论

在电重构心房中,阻断I(Kur)/I(to)/I(KAch)可恢复I(Kr)阻滞剂的Ⅲ类作用。输注AVE0118与多非利特或伊布利特的组合可有效转复持续性AF。这种抗纤颤作用与心房内折返径路几乎延长两倍有关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验